Chlorhexidine Intracanal Medicament in Periodontal Healing in Concomitant Endo Perio Lesion With Communication
Periodontal Pocket, Tooth,Non Vital
About this trial
This is an interventional treatment trial for Periodontal Pocket focused on measuring chlorhexidine, endodontic treatment
Eligibility Criteria
Inclusion Criteria:
Patients of age between 18-55 years with generalized chronic periodontitis and having at least one tooth with concomitant endodontic periodontal lesion with communication including following features:
- a clinical and radiographic diagnosis of concomitant endodontic periodontal lesion
- Wide base pocket, deep probing pocket depth
- Non vital tooth with periapical radiolucency
- Radiographic alveolar bone (marginal bone) destruction with apical communication Criteria for generalized chronic periodontitis [≥30% sites involved with clinical attachment loss (CAL) 1-2mm (mild) or 3-4mm (moderate) or ≥5mm (severe)]40 Patient should have more than 20 teeth
Exclusion Criteria:Systemic illness known to affect the periodontium or outcome of periodontal therapy.
- Patient taking medications such as corticosteroids or calcium channel blockers, which are known to interfere periodontal wound healing or patient on long term NSAID therapy or bisphosphonates.
- Patients allergic to medication (local anaesthetic, antibiotics, NSAID).
- Patients with acute symptoms.
- Pregnant or lactating females.
- Smokers (current and past) and tobacco chewers.
- Grade 3 mobile teeth.
- Unrestorable tooth.
- Root resorption.
- Fractured/perforated roots.
- Developing permanent tooth.
- Abutments.
- Previously root canal filled.
- Patients with aggressive periodontitis
- History of periodontal treatment within 6 months prior to study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Group 1
Group 2 Chlorhexidine
Interventions done in 30 patients and included conventional endodontic treatment (ET) and periodontal surgery . After 3 months of completion of endodontic therapy without using 2%chlorhexidine gluconate gel intracanal medicament , periodontal surgery in the form of open flap debridement (OFD) was performed.
Interventions done in 30 patients and included intracanal medicament . After biomechanical preparation of root canal, 2%Chlorhexidine gluconate gel as an intracanal medicament was placed in root canal from pulp chamber to apex for 3 months (replacing every month). After 3 months,periodontal surgery in the form of open flap debridement (OFD) was performed in the respective tooth and medicament was changed and placed further for 3 months (replacing every month). Obturation was done after 3 months of OFD.